PL111183B1 - Method of obtaining a cephaloxine preparation - Google Patents
Method of obtaining a cephaloxine preparation Download PDFInfo
- Publication number
- PL111183B1 PL111183B1 PL1977198058A PL19805877A PL111183B1 PL 111183 B1 PL111183 B1 PL 111183B1 PL 1977198058 A PL1977198058 A PL 1977198058A PL 19805877 A PL19805877 A PL 19805877A PL 111183 B1 PL111183 B1 PL 111183B1
- Authority
- PL
- Poland
- Prior art keywords
- cephalexin
- preparation
- hours
- time
- curve
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Cephalosporin Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP5492576A JPS52139713A (en) | 1976-05-13 | 1976-05-13 | Sustained release cefalexin preparations |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PL198058A1 PL198058A1 (pl) | 1979-03-26 |
| PL111183B1 true PL111183B1 (en) | 1980-08-30 |
Family
ID=12984185
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL1977198058A PL111183B1 (en) | 1976-05-13 | 1977-05-12 | Method of obtaining a cephaloxine preparation |
Country Status (27)
| Country | Link |
|---|---|
| JP (1) | JPS52139713A (cs) |
| AR (1) | AR224494A1 (cs) |
| AT (1) | AT351159B (cs) |
| AU (1) | AU508793B2 (cs) |
| BE (1) | BE854640A (cs) |
| CA (1) | CA1085296A (cs) |
| CS (1) | CS208196B2 (cs) |
| DD (1) | DD132232A5 (cs) |
| DE (1) | DE2721785A1 (cs) |
| DK (1) | DK208077A (cs) |
| ES (1) | ES458710A1 (cs) |
| FI (1) | FI771491A7 (cs) |
| FR (1) | FR2350836A1 (cs) |
| GB (1) | GB1543543A (cs) |
| GR (1) | GR68895B (cs) |
| HU (1) | HU184196B (cs) |
| IE (1) | IE45415B1 (cs) |
| IL (1) | IL52075A (cs) |
| MX (1) | MX5976E (cs) |
| NL (1) | NL7704879A (cs) |
| NZ (1) | NZ183927A (cs) |
| PL (1) | PL111183B1 (cs) |
| PT (1) | PT66514B (cs) |
| RO (1) | RO72935A (cs) |
| SE (1) | SE426780B (cs) |
| SU (1) | SU1218919A3 (cs) |
| ZA (1) | ZA772757B (cs) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5545601A (en) * | 1978-09-26 | 1980-03-31 | Toyo Jozo Co Ltd | Long-acting cephalexin and its preparation |
| FR2453639A1 (fr) * | 1979-04-09 | 1980-11-07 | Sanofi Sa | Composition medicamenteuse a liberation programmee immediate-retard a base de naftidrofuryl |
| JPS5659707A (en) * | 1979-10-19 | 1981-05-23 | Toyo Jozo Co Ltd | Lasting antibiotic pharmaceutical and its preparation |
| JPS5826816A (ja) * | 1981-08-11 | 1983-02-17 | Teisan Seiyaku Kk | 球形顆粒からなる持続性複合顆粒剤 |
| JPS5846019A (ja) * | 1981-09-14 | 1983-03-17 | Kanebo Ltd | 持続性ニフエジピン製剤 |
| JPS5883613A (ja) * | 1981-11-10 | 1983-05-19 | Toa Eiyou Kagaku Kogyo Kk | 硝酸イソソルビト−ル製剤 |
| JPS5883106U (ja) * | 1981-11-30 | 1983-06-06 | 松下電工株式会社 | 電磁石装置に於けるオイルダツシユポツト |
| US4525339A (en) * | 1982-10-15 | 1985-06-25 | Hoffmann-La Roche Inc. | Enteric coated oral dosage form |
| JPS601128A (ja) * | 1983-06-15 | 1985-01-07 | Shionogi & Co Ltd | 作用持続型セフアクロル製剤 |
| JPS6144811A (ja) * | 1984-08-10 | 1986-03-04 | Ss Pharmaceut Co Ltd | 徐放性ジクロフエナクナトリウム製剤 |
| FR2577800B1 (fr) * | 1985-02-22 | 1990-09-07 | Grimberg Georges | Medicament sous forme galenique gastro-resistante |
| JPS62226926A (ja) * | 1986-03-27 | 1987-10-05 | Teisan Seiyaku Kk | 持続性複合顆粒剤 |
| JP2008535922A (ja) * | 2005-04-12 | 2008-09-04 | エラン・ファルマ・インターナショナル・リミテッド | 細菌感染を治療するためのセファロスポリンを含む放出制御組成物 |
| CN114617855A (zh) * | 2020-12-14 | 2022-06-14 | 江苏贝佳制药有限公司 | 头孢氨苄胶囊的制备方法 |
-
1976
- 1976-05-13 JP JP5492576A patent/JPS52139713A/ja active Granted
-
1977
- 1977-04-20 CA CA276,514A patent/CA1085296A/en not_active Expired
- 1977-04-26 NZ NZ183927A patent/NZ183927A/xx unknown
- 1977-05-03 NL NL7704879A patent/NL7704879A/xx active Search and Examination
- 1977-05-05 PT PT66514A patent/PT66514B/pt unknown
- 1977-05-09 ZA ZA00772757A patent/ZA772757B/xx unknown
- 1977-05-09 IE IE940/77A patent/IE45415B1/en unknown
- 1977-05-11 ES ES458710A patent/ES458710A1/es not_active Expired
- 1977-05-11 SE SE7705502A patent/SE426780B/xx not_active IP Right Cessation
- 1977-05-11 FI FI771491A patent/FI771491A7/fi not_active Application Discontinuation
- 1977-05-11 AU AU25078/77A patent/AU508793B2/en not_active Expired
- 1977-05-11 DK DK208077A patent/DK208077A/da not_active Application Discontinuation
- 1977-05-11 GB GB19853/77A patent/GB1543543A/en not_active Expired
- 1977-05-12 HU HU77SI1575A patent/HU184196B/hu unknown
- 1977-05-12 MX MX775739U patent/MX5976E/es unknown
- 1977-05-12 PL PL1977198058A patent/PL111183B1/pl unknown
- 1977-05-12 RO RO7790312A patent/RO72935A/ro unknown
- 1977-05-12 GR GR53444A patent/GR68895B/el unknown
- 1977-05-12 FR FR7714616A patent/FR2350836A1/fr active Granted
- 1977-05-12 IL IL52075A patent/IL52075A/xx unknown
- 1977-05-12 AT AT341877A patent/AT351159B/de not_active IP Right Cessation
- 1977-05-12 SU SU772485596A patent/SU1218919A3/ru active
- 1977-05-13 BE BE177585A patent/BE854640A/xx unknown
- 1977-05-13 CS CS773167A patent/CS208196B2/cs unknown
- 1977-05-13 DD DD7700198922A patent/DD132232A5/xx unknown
- 1977-05-13 DE DE19772721785 patent/DE2721785A1/de active Granted
- 1977-05-13 AR AR267621A patent/AR224494A1/es active
Also Published As
| Publication number | Publication date |
|---|---|
| SE426780B (sv) | 1983-02-14 |
| AU508793B2 (en) | 1980-04-03 |
| DK208077A (da) | 1977-11-14 |
| MX5976E (es) | 1984-09-12 |
| FR2350836B1 (cs) | 1981-02-06 |
| ZA772757B (en) | 1978-04-26 |
| NL7704879A (nl) | 1977-11-15 |
| JPS5547611B2 (cs) | 1980-12-01 |
| JPS52139713A (en) | 1977-11-21 |
| IL52075A0 (en) | 1977-07-31 |
| FI771491A7 (cs) | 1977-11-14 |
| IE45415L (en) | 1977-11-13 |
| GB1543543A (en) | 1979-04-04 |
| ATA341877A (de) | 1978-12-15 |
| NZ183927A (en) | 1980-02-21 |
| PL198058A1 (pl) | 1979-03-26 |
| PT66514A (en) | 1977-06-01 |
| DE2721785C2 (cs) | 1989-03-16 |
| BE854640A (fr) | 1977-09-01 |
| CA1085296A (en) | 1980-09-09 |
| IE45415B1 (en) | 1982-08-25 |
| SE7705502L (sv) | 1977-11-14 |
| PT66514B (en) | 1978-10-16 |
| CS208196B2 (en) | 1981-08-31 |
| DD132232A5 (de) | 1978-09-13 |
| ES458710A1 (es) | 1978-03-01 |
| RO72935A (ro) | 1982-07-06 |
| DE2721785A1 (de) | 1977-11-24 |
| SU1218919A3 (ru) | 1986-03-15 |
| AU2507877A (en) | 1978-11-16 |
| AT351159B (de) | 1979-07-10 |
| GR68895B (cs) | 1982-03-15 |
| AR224494A1 (es) | 1981-12-15 |
| HU184196B (en) | 1984-07-30 |
| FR2350836A1 (fr) | 1977-12-09 |
| IL52075A (en) | 1980-06-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1940361B1 (en) | Pharmaceutical dosage forms having immediate release and/or controlled release properties | |
| US4250166A (en) | Long acting preparation of cefalexin for effective treatments of bacterial infection sensitive to cefalexin | |
| JP6530772B2 (ja) | アンチセンス組成物およびその作製および使用 | |
| CA2104686C (en) | Delayed release oral dosage forms for treatment of intestinal disorders | |
| KR100270491B1 (ko) | 약제 송출 시스템 및 그의 제조방법 | |
| US8968777B2 (en) | Tranexamic acid formulations with reduced adverse effects | |
| JPH09500617A (ja) | 腸管の異常ｐＨ値の調整及び腸疾患の処置のために使用する組成物 | |
| PL111183B1 (en) | Method of obtaining a cephaloxine preparation | |
| SK279358B6 (sk) | Farmaceutický aplikačný prostriedok a spôsob jeho | |
| IE850744L (en) | Storage-stable, quick-disintegrating pharmaceuticals | |
| AU731693B2 (en) | Drug formulation having controlled release of active compound | |
| AU702934B2 (en) | Modified release oral pharmaceutical composition containing 5-asa and method for the treatment of bowel diseases | |
| US4976949A (en) | Controlled release dosage form | |
| US20240082168A1 (en) | Controlled drug release formulation | |
| CA2672686A1 (en) | Pharmaceutical formulations | |
| Kadiyala et al. | The study of marketed and experimental formulation approaches enabling site-specific delivery of mesalamine in patients with inflammatory bowel disease | |
| WO2002066004A1 (en) | Compositions with controlled drug release | |
| AU2022392482A1 (en) | Controlled release formulations of flavoxate and process for preparation thereof | |
| MX2008004282A (en) | Pharmaceutical dosage forms having immediate release and/orcontrolled release properties |